“If that would have lessened my symptoms, that would have been great...”: a qualitative study about the acceptability of tecovirimat as treatment for mpox by Sara Paparini, Rosalie Hayes, Benjamin Weil, Will Nutland, Ismael Maatouk, Teodora Wi, Chloe M. Orkin, Rosamund Lewis

Get full text

Reduced expression of IFIH1 is protective for type 1 diabetes. by Kate Downes, Marcin Pekalski, Karen L Angus, Matthew Hardy, Sarah Nutland, Deborah J Smyth, Neil M Walker, Chris Wallace, John A Todd

Get full text

Mpox stigma in the UK and implications for future outbreak control: a cross-sectional mixed methods study by Amy Paterson, Ashleigh Cheyne, Harun Tulunay, Chloe Orkin, Will Nutland, Jake Dunning, Jeni Stolow, Nina Gobat, Piero Olliaro, Amanda Rojek, Outbreak Stigma Assessment Expert Group

Get full text

Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study. by Mitzy Gafos, Elizabeth Brodnicki, Monica Desai, Sheena McCormack, Will Nutland, Sonali Wayal, Ellen White, Gemma Wood, Tristan Barber, Gill Bell, Amanda Clarke, David Dolling, David Dunn, Julie Fox, Lewis Haddow, Charles Lacey, Anthony Nardone, Killian Quinn, Caroline Rae, Iain Reeves, Michael Rayment, David White, Vanessa Apea, Wilbert Ayap, Claire Dewsnap, Yolanda Collaco-Moraes, Gabriel Schembri, Yinka Sowunmi, Rob Horne, PROUD Study Team

Get full text